AU1598500A - Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2 - Google Patents

Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2

Info

Publication number
AU1598500A
AU1598500A AU15985/00A AU1598500A AU1598500A AU 1598500 A AU1598500 A AU 1598500A AU 15985/00 A AU15985/00 A AU 15985/00A AU 1598500 A AU1598500 A AU 1598500A AU 1598500 A AU1598500 A AU 1598500A
Authority
AU
Australia
Prior art keywords
hla
specific peptide
peptide epitopes
melanoma antigen
antigen trp2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15985/00A
Inventor
Yutaka Kawakami
Maria R. Parkhurst
Paul F Robbins
Steven A Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU1598500A publication Critical patent/AU1598500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU15985/00A 1998-10-26 1999-10-22 Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2 Abandoned AU1598500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10557798P 1998-10-26 1998-10-26
US60105577 1998-10-26
PCT/US1999/024887 WO2000024778A1 (en) 1998-10-26 1999-10-22 Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2

Publications (1)

Publication Number Publication Date
AU1598500A true AU1598500A (en) 2000-05-15

Family

ID=22306609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15985/00A Abandoned AU1598500A (en) 1998-10-26 1999-10-22 Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2

Country Status (2)

Country Link
AU (1) AU1598500A (en)
WO (1) WO2000024778A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476535B2 (en) * 2001-03-19 2009-01-13 The United States Of America As Represented By The Department Of Health And Human Services TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes
US20030113919A1 (en) * 2001-08-17 2003-06-19 Aventis Pasteur, Ltd. Immunogenic targets for melanoma
US8067535B2 (en) * 2003-01-24 2011-11-29 The University Of Massachusetts Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes
ATE516045T1 (en) 2003-01-24 2011-07-15 Univ Massachusetts Medical IDENTIFICATION OF VACCINIA VIRUS-DOMINANT T-CELL EPITOPES
US7939090B2 (en) 2003-10-21 2011-05-10 Cedars-Sinai Medical Center System and method for the treatment of cancer, including cancers of the central nervous system
AT502292B1 (en) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology MELANOMA DIAGNOSIS
DE102005041616B4 (en) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanoma associated MHC class I associated oligopeptides and polynucleotides encoding them and their uses
CA2700573C (en) 2006-09-26 2016-11-22 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
CA2700436C (en) 2006-09-28 2017-04-18 John S. Yu Cancer vaccines and vaccination methods
EP2328923B1 (en) 2008-09-02 2016-01-13 Cedars-Sinai Medical Center Cd133 epitopes
ES2618573T3 (en) 2009-05-07 2017-06-21 ImmunoCellular Therapeutics,Ltd CD133 epitopes
EP2956544B1 (en) 2013-02-14 2017-11-01 Immunocellular Therapeutics Ltd. Cancer vaccines and vaccination methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

Also Published As

Publication number Publication date
WO2000024778A1 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
PL345541A1 (en) Antigenic peptides derived from telomerase
HK1096974A1 (en) Antibody against human parathormone related peptides
AU2395895A (en) Melanoma antigens
PL341160A1 (en) Novel superficial antigen
AU7163298A (en) Semiconductor micro-resonator device
FI20115005A (en) Melanoma antigen
AU6868398A (en) Mu-opiate receptor peptides
PT2261358E (en) Novel streptococcus antigen
AU2089899A (en) Improved seat cover
AU6140998A (en) Peptides and peptide-loaded antigen presenting cells for the activation of ctl
ZA952374B (en) Isolated peptides derived from MAGE antigen precursors which complex with HLA-A2 molecules and uses thereof
AU1951201A (en) Peptide antigens
AU1598500A (en) Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2
EP1055684A4 (en) Tumor antigen peptide derivatives
HK1046925A1 (en) Mage-a12 antigenic peptides and uses thereof
EP0888126A4 (en) Anti-idiotypic antibody vaccines
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
AU1108400A (en) Antigenic epitopes with lym-1 reactivity and uses thereof
EP0984065A4 (en) Modified treponema pallidum-derived antigen protein
ZA978027B (en) The use of muramyl peptides
GB9726147D0 (en) Antigens
AU6602896A (en) H-y derived epitopes and uses therefor
AU5406098A (en) Antigenic peptides reacting with anti-ovary antibodies
AU6001499A (en) Tumor-specific antigen peptides
AU9109098A (en) Hypusine peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase